Webinar: Optimising viral vector manufacturing with CDMO expertise and innovation

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category

Analyst coverage

The following analyst cover OXB:

Company Analyst Telephone
Deutsche Numis Kane Slutzkin +44 (0) 20 7545 4624
Investec Jens Lindqvist +44 (0) 20 7597 5590
Jefferies James Vane-Tempest +44 (0) 20 7029 8275
JP Morgan Zain Ebrahim +44 (0) 20 3493 1163
Panmure Liberum Julie Simmonds +44 (0) 20 7886 2743
Peel Hunt Miles Dixon +44 (0) 20 3597 8663
RBC Charles Weston +44 (0) 20 7429 8425
Stifel James Orsborne & Christian +44 (0) 20 7710 7638
OXB-Investors-Analyst-image-grid-2-832x480px
OXB-Investors-Analyst-image-grid-3-832x480px
OXB-Investors-Analyst-image-grid-1-832x480px